Quarterly report pursuant to Section 13 or 15(d)

Organization and Nature of Operations (Details)

v3.22.1
Organization and Nature of Operations (Details) - shares
1 Months Ended 3 Months Ended
Oct. 19, 2016
Mar. 31, 2022
Apr. 06, 2022
Jul. 31, 2017
Aug. 07, 2015
Organization and Nature of Operations (Details) [Line Items]          
Exchange for common stock (in Shares) 50,000,000        
Percentage of capital stock   100.00%      
Avalon RT 9 Properties, LLC [Member]          
Organization and Nature of Operations (Details) [Line Items]          
Building occupancy rate   83.50%      
Beijing Jieteng (GenExosome) Biotech Co., Ltd. [Member]          
Organization and Nature of Operations (Details) [Line Items]          
Ownership percentage       100.00%  
GenExosome Technologies Inc. [Member]          
Organization and Nature of Operations (Details) [Line Items]          
Ownership percentage         60.00%
Dr. Yu Zhou [Member]          
Organization and Nature of Operations (Details) [Line Items]          
Ownership percentage         40.00%
Avactis Biosciences Inc. [Member] | Subsequent Event [Member]          
Organization and Nature of Operations (Details) [Line Items]          
Ownership percentage     60.00%    
Series of Individually Immaterial Business Acquisitions [Member]          
Organization and Nature of Operations (Details) [Line Items]          
Business acquired percentage 100.00%